Compositions of A-8R peptide
The present invention provides materials and methods useful to treat various sGCα1-expressing cancers. Materials include peptides which interfere with sGCα1's pro-survival functions, thereby resulting in apoptosis of sGCα1-expressing cells. In addition, the present invention provides screening assays, diagnostic assays, methods to prognose, methods to treat, and kits.
1. A composition of matter comprising a peptide consisting of the amino acid sequence set forth in SEQ ID NO:1.
2. A pharmaceutical composition comprising:
a composition of claim 1 ; and
a composition selected from the group consisting of: an adjuvant, a pharmaceutically-acceptable salt, a prodrug, a buffer, and a biomarker.
3. A composition of claim 1 , which further comprises a chemotherapeutic agent.
4. A composition of claim 3 , wherein the chemotherapeutic agent is etoposide.